Company: MBVI
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001213900-25-110004
Chunk: 34

Company: M3-Brigade Acquisition VI Corp.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 34
---
 of the disclosure controls and procedures are met.
Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits
must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation
of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances
of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of
future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial
Reporting

There was no change in our internal control over
financial reporting that occurred during the fiscal quarter of 2025 covered by this Quarterly Report on Form 10-Q that has materially
affected, or is reasonably likely to materially affect, our internal control over financial reporting.

20

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

To the knowledge of our management, there is no
material litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against
any of our property.

Item 1A. Risk Factors

Factors that could cause our actual results to
differ materially from those in this Quarterly Report include the risk factors described in our final prospectus for our Initial Public
Offering filed with the SEC. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed
in our final prospectus for our Initial Public Offering filed with the SEC.

Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds.

Unregistered Sales of Equity Securities

On June 6, 2025, the Sponsor made a capital contribution
of $25,000, or approximately $0.003 per share, to cover certain of the Company’s expenses, for which the Company issued 8,625,000
founder shares to the Sponsor. The foregoing issuance was made pursuant to the exemption from registration contained in Section 4(a)(2)
of the Securities Act.

On August 28, 2025, the Company consummated the
Initial Public Offering of 34,500,000 Units, which includes the full exercise by the underwriters of their over-allotment option in the
amount of 4,500,000 Units, at $10.00 per Unit, generating gross proceeds of $345,000,000. The securities sold